Problem Management Plus (PM+) in Chile: a Pilot Randomized Controlled Trial of a Psychological Transdiagnostic Intervention Delivered in Primary Health Care

Last updated: November 17, 2025
Sponsor: University of Chile
Overall Status: Completed

Phase

N/A

Condition

Anxiety Disorders

Depression

Mood Disorders

Treatment

Problem Management Plus (PM+)

Clinical Study ID

NCT06988332
390
  • Ages > 18
  • All Genders

Study Summary

This study aims to evaluate the implementation outcomes of a pilot randomized controlled trial and to assess the preliminary efficacy of Problem Management Plus (PM+) in reducing symptoms of depression and anxiety among users at a Primary Health Care center in Chile.

Two intervention groups will be compared: PM+ versus care as usual (CAU). The process will include an evaluation of the feasibility of the study procedures, as well as the acceptability and fidelity of the PM+ intervention.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Individuals over 18 years old.

  • Diagnosed with or presenting depressive and/or anxiety symptoms (through screening).

  • Residents of the selected study region.

  • Part of the population enrolled and validated in the pilot primary health carefacilities.

Exclusion

Exclusion Criteria:

  • Suicidal risk requiring immediate or urgent referral to care services.

  • Suffering from severe psychiatric disorders or substance use disorders.

  • Being in situations of declared risk that require protection (e.g., domesticviolence).

  • Moderate or severe disability.

  • Incapacitating medical illnesses.

  • Receiving other mental health treatments that could lead to over-intervention.

Study Design

Total Participants: 56
Treatment Group(s): 1
Primary Treatment: Problem Management Plus (PM+)
Phase:
Study Start date:
May 09, 2025
Estimated Completion Date:
October 12, 2025

Study Description

In Chile, only 19% of the population with mental health conditions has access to primary care services, highlighting the urgent need to expand mental health care availability. Training more healthcare professionals to deliver low-intensity psychological interventions could be a valuable approach to addressing this disparity.

The World Health Organization's Problem Management Plus (PM+) is a low-intensity, transdiagnostic, peer-delivered intervention designed for implementation in resource-limited settings to address common mental health disorders. In this context, PM+ serves as an evidence-based strategy that can help reduce gaps in healthcare services, particularly regarding availability and accessibility.

This study aims to evaluate the implementation outcomes of a pilot randomized clinical trial, including feasibility, acceptability and fidelity and to assess the preliminary efficacy of PM+ in reducing mental health symptoms among users at a primary healthcare center in Chile.

The study design is a single-blind pilot randomized controlled trial with a 1:1 allocation ratio, assessing two intervention arms for participants with depressive and/or anxiety symptoms over five weeks.

The study population consists of adults of 18 years or above with mild to moderate depressive and/or anxiety symptoms, living in the selected study region and enrolled in the primary health care center chosen to conduct the trial.

Two groups will be compared. The treatment group will receive five sessions of PM+. The control group will receive care as usual (CAU), which includes the regular mental health services provided at the primary health care center selected for the study.

Implementation outcomes of PM+ will be assessed, focusing mainly on feasibility, acceptability and fidelity. Additionally, preliminary efficacy outcomes of depression, anxiety and self-identified problems will be evaluated.

Connect with a study center

  • CESFAM Las Ánimas

    Valdivia,
    Chile

    Site Not Available

  • CESFAM Las Ánimas

    Valdivia 3868707,
    Chile

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.